SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 09, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and contains no financial performance data.
Material Changes
The only material change disclosed is a transaction involving Mr. Andrew P. Witty, a Director. On May 09, 2007, he transferred 25 Ordinary shares in GlaxoSmithKline plc by way of gift. The company was advised of this transaction on the same date.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transfer in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: May 09, 2007
- Individual Involved: Mr. Andrew P. Witty (Director)
- Transaction Type: Transfer by way of gift
- Quantity: 25 Ordinary Shares
- Regulatory Basis: Disclosure Rule 3.1.4R(1)(a)